Chesnara Plc: Fourth acquisition in two years
12 November 2026
REGENXBIO Inc. (NASDAQ: RGNX) is a name making waves in the biotechnology sector with its innovative approach to tackling genetic disorders through gene therapy. As a..
Relay Therapeutics, Inc. (NASDAQ: RLAY) stands out in the biotechnology sector as a clinical-stage precision medicines company focusing on advancing small molecule therapeutic discovery in targeted..
Evolus, Inc. (NASDAQ: EOLS), a prominent player in the healthcare sector, is drawing significant attention from investors with its potential upside of 263.94%. As a company..
Valneva SE (NASDAQ: VALN), a French biotechnology company specializing in prophylactic vaccines, is capturing the attention of investors due to its significant potential upside of 119.26%,..
For investors eyeing the biotechnology sector, Nurix Therapeutics, Inc. (NASDAQ: NRIX) presents an intriguing opportunity. This clinical-stage biopharmaceutical firm, headquartered in Brisbane, California, is pioneering advancements..
Gyre Therapeutics, Inc. (NASDAQ: GYRE), a prominent player in the biotechnology sector, is currently turning heads with its impressive potential upside of 162.17%, according to recent..
InnovAge Holding Corp. (NASDAQ: INNV), a prominent player in the healthcare sector, particularly within the medical care facilities industry, has been making headlines with its innovative..
Xencor, Inc. (XNCR), a prominent player in the biotechnology industry, stands out with its promising potential upside of 121.83%, making it a stock worth considering for..
HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the Health Information Services industry, is drawing attention from investors with its strategic position in the burgeoning Software-as-a-Service..
CareDx, Inc. (CDNA) is a key player in the healthcare sector, specializing in diagnostics and research aimed at improving outcomes for transplant patients. Headquartered in Brisbane,..
Immunome, Inc. (NASDAQ: IMNM) is capturing investor attention with its impressive potential upside of 62.72%, according to recent analyst ratings. With a focus on developing innovative..
Investors with a keen eye on the biotechnology sector might find Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) a compelling addition to their portfolios. With a market cap..
Sionna Therapeutics, Inc. (NASDAQ: SION), a burgeoning player in the biotechnology sector, is drawing significant attention from investors, driven largely by its impressive 21.29% potential upside..
Delcath Systems, Inc. (NASDAQ: DCTH) is capturing investor attention with its innovative approach to cancer treatment and a compelling potential upside of over 121%. Specializing in..
Trevi Therapeutics, Inc. (NASDAQ: TRVI), a biotechnology firm focused on developing treatments for chronic cough conditions, presents a compelling investment opportunity with an impressive potential upside..
For investors with an eye on the healthcare sector, Zymeworks Inc. (NASDAQ: ZYME) presents a compelling opportunity within the biotechnology industry. Based in Middletown, Delaware, Zymeworks..
Investors seeking opportunities in the healthcare sector might find Vir Biotechnology, Inc. (NASDAQ: VIR) an intriguing candidate, particularly given its robust analyst ratings and significant potential..
Enliven Therapeutics, Inc. (NASDAQ: ELVN) has been capturing significant attention in the biotechnology sector, with analysts unanimously rating it as a “Buy.” As a clinical-stage biopharmaceutical..
Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company headquartered in Langhorne, Pennsylvania, is capturing the attention of investors with its promising pipeline in the treatment of..
Avadel Pharmaceuticals plc (NASDAQ: AVDL), a biopharmaceutical company based in Dublin, Ireland, has been capturing investor attention with its robust revenue growth of 54.90%. Specializing in..
